StockData

iQSTEL vs SurgePays

IQST and SURG side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IQST and SURG compare

iQSTEL is the larger company, worth 38 times as much as SurgePays ($278M against $7.2M).

iQSTEL keeps more of each dollar of sales as profit, with a net margin of −2.2% compared with −47.9% at SurgePays.

iQSTEL scores higher on the StockData Score (6 against 1 for SurgePays), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIQSTSURG
Size and price
Market cap$278M$7.2M
Share price$0.690$0.137
Change, 1 year−86.6%−93.2%
Change, 5 years−98.3%−94.3%
Beta (5Y)0.972.51
Employees10030
StockData Score
Total score6 (better)1
Valuation score01 (better)
Growth score2 (better)0
Performance score1 (better)0
Health score3 (better)0
Dividend score00
Valuation
P/S0.7×0.1× (better)
P/B16.2×–
FCF yield−1.4%–
Growth
Revenue growth (TTM)39.3%–
Revenue growth, 5Y average37.4% (better)0.92%
Profitability
Gross margin2.7% (better)−19.6%
Operating margin−1.3% (better)−41.0%
Net margin−2.2% (better)−47.9%
FCF margin−0.99%–
Return on equity−56.0%–
Return on invested capital−23.3%–
Financial health
Debt / equity0.15–
Interest coverage–−15.3×
Current ratio1.09 (better)0.19
Altman Z-score11.90 (better)−21.51
Piotroski F-score33
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions0.06%4.4%
Held by insiders0.00%9.2%
Insider net buying, 12 months–$83.0K
Short interest, % of float0.10%9.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.